EMA-2023-0022-V222
Major variation for application EMA-2023-0022. Major variation: Container Closure Change for Respiralimab — major revision
Variation Number
EMA-2023-0022-V222
Type
Major
Application
Change
Status
Overdue
Fee
€30,485
Submitted
2023-11-24
Approved
—
Description
Major variation: Container Closure Change for Respiralimab — major revision